COVID-19 Vaccine | Demand Inquiry

20 January 2021

Dear Members and Friends,

China-Italy Chamber of Commerce is currently in discussion with Fosun Pharma to provide primary access to the Fosun/BioNTech COVID-19 vaccine (also known as the Pfizer/BioNTech's mRNA vaccine) to CICC’s Members and for Friends of CICC, including their employees and family members.

The vaccine has already been approved and started to be used –among others- in the United States and in Europe, whereas in China so far the Fosun/BioNTech COVID-19 vaccine has not been approved. 

To provide support to its Members and Friends, CICC publishes a survey to understand the demand for the vaccine. If interested, please fill out the following survey before January 27th.

 

Access the survey: 

 

 

The survey does not represent a guarantee of:

  • The approval and delivery of the vaccine in China;
  • Delivery of the requested demand.

 

CICC does not currently have any additional information on the matter. We will update our Members and Friends as soon as we will receive further details.

 

Please note: All information collected will only be used to determine the number of people interested in the vaccine and will not be distributed elsewhere.

 

Thank you for your support and cooperation.

 

Best Regards,

China-Italy Chamber of Commerce

Copyright ©2016 by China-Italy Chamber of Commerce
Website maintenance by flow.asia
京ICP备06006969号-1